Veracyte to Participate in the Raymond James 45th Annual Institutional Investors Conference
February 21 2024 - 5:00PM
Business Wire
Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley,
chief executive officer, and John Leite, Ph.D., chief commercial
officer, CLIA, will present at the Raymond James 45th Annual
Institutional Investors Conference on Monday, March 4, 2024, at
9:50 a.m. Eastern Time.
A live audio webcast of the company’s presentation will be
available by visiting Veracyte’s website at
http://investor.veracyte.com/events-presentations. A replay of the
webcast will be available for 90 days following the conclusion of
the live broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose
vision is to transform cancer care for patients all over the world.
We empower clinicians with the high-value insights they need to
guide and assure patients at pivotal moments in the race to
diagnose and treat cancer. Our Veracyte Diagnostics Platform
delivers high-performing cancer tests that are fueled by broad
genomic and clinical data, deep bioinformatic and AI capabilities,
and a powerful evidence-generation engine, which ultimately drives
durable reimbursement and guideline inclusion for our tests, along
with new insights to support continued innovation and pipeline
development. For more information, please visit www.veracyte.com or
follow us on LinkedIn or X (Twitter).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240221354545/en/
Investors Shayla Gorman investors@veracyte.com (619)
393-1545
Media Tracy Morris media@veracyte.com (650) 380-4413
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From Apr 2024 to May 2024
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From May 2023 to May 2024